US › Healthcare

Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.370.00%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$53.0M

Net profit

$-47.2M

EPS

$-0.46

EPS estimate

$0.00

Net margin

-89.0%

Key statistics

Market cap

$73.5M

Forward P/E

0.0

P/B

2.00

Book value

$0.78

EPS (TTM)

$-0.22

52-week high

$11.45

52-week low

$0.62

50-day MA

$1.59

200-day MA

$1.22

Shareholding

Insiders

16.16%

Institutions

0.91%

Largest institutional holders

Fund	Stake
XTX Topco Ltd	0.09%
Geode Capital Management, LLC	0.06%
Winton Capital Group Ltd	0.03%
UBS Group AG	0.02%
Tower Research Capital LLC	0.01%
Royal Bank of Canada	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Caitong International Asset Management Co., Limited.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Zhengye Biotechnology Holding Limited Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.